Publisher Correction: SARS-CoV-2 and HIV-1 — a tale of two vaccines

Barton F. Haynes

DOI: https://doi.org/10.1038/s41577-021-00604-0

IF: 108.555

2021-08-04

Nature Reviews Immunology

Abstract:Nature Reviews Immunology, Published online: 04 August 2021; doi:10.1038/s41577-021-00604-0Publisher Correction: SARS-CoV-2 and HIV-1 — a tale of two vaccines

immunology

What problem does this paper attempt to address?

Corrigendum To: Genomic Diversity of Severe Acute Respiratory Syndrome–Coronavirus 2 in Patients with Coronavirus Disease 2019

Zijie Shen,Yan Xiao,Lu Kang,Wentai Ma,Leisheng Shi,Li Zhang,Zhuo Zhou,Jing Yang,Jiaxin Zhong,Donghong Yang,Li Guo,Guoliang Zhang,Hongru Li,Yu Xu,Mingwei Chen,Zhancheng Gao,Jianwei Wang,Lili Ren,Mingkun Li

DOI: https://doi.org/10.1093/cid/ciab900

2020-01-01

Abstract:Background. A novel coronavirus (CoV), severe acute respiratory syndrome (SARS)-CoV-2, has infected >75 000 individuals and spread to >20 countries. It is still unclear how fast the virus evolved and how it interacts with other microorganisms in the lung. Methods. We have conducted metatranscriptome sequencing for bronchoalveolar lavage fluid samples from 8 patients with SARS-CoV-2, and also analyzed data from 25 patients with community-acquired pneumonia (CAP), and 20 healthy controls for comparison. Results. The median number of intrahost variants was 1-4 in SARS-CoV-2-infected patients, ranged from 0 to 51 in different samples. The distribution of variants on genes was similar to those observed in the population data. However, very few intrahost variants were observed in the population as polymorphisms, implying either a bottleneck or purifying selection involved in the transmission of the virus, or a consequence of the limited diversity represented in the current polymorphism data. Although current evidence did not support the transmission of intrahost variants in a possible person-to-person spread, the risk should not be overlooked. Microbiotas in SARS-CoV-2-infected patients were similar to those in CAP, either dominated by the pathogens or with elevated levels of oral and upper respiratory commensal bacteria. Conclusion. SARS-CoV-2 evolves in vivo after infection, which may affect its virulence, infectivity, and transmissibility. Although how the intrahost variant spreads in the population is still elusive, it is necessary to strengthen the surveillance of the viral evolution in the population and associated clinical changes.
Publisher Correction: A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity

Jingyun Yang,Wei Wang,Zimin Chen,Shuaiyao Lu,Fanli Yang,Zhenfei Bi,Linlin Bao,Fei Mo,Xue Li,Yong Huang,Weiqi Hong,Yun Yang,Yuan Zhao,Fei Ye,Sheng Lin,Wei Deng,Hua Chen,Hong Lei,Ziqi Zhang,Min Luo,Hong Gao,Yue Zheng,Yanqiu Gong,Xiaohua Jiang,Yanfeng Xu,Qi Lv,Dan Li,Manni Wang,Fengdi Li,Shunyi Wang,Guanpeng Wang,Pin Yu,Yajin Qu,Li Yang,Hongxin Deng,Aiping Tong,Jiong Li,Zhenling Wang,Jinliang Yang,Guobo Shen,Zhiwei Zhao,Yuhua Li,Jingwen Luo,Hongqi Liu,Wenhai Yu,Mengli Yang,Jingwen Xu,Junbin Wang,Haiyan Li,Haixuan Wang,Dexuan Kuang,Panpan Lin,Zhengtao Hu,Wei Guo,Wei Cheng,Yanlin He,Xiangrong Song,Chong Chen,Zhihong Xue,Shaohua Yao,Lu Chen,Xuelei Ma,Siyuan Chen,Maling Gou,Weijin Huang,Youchun Wang,Changfa Fan,Zhixin Tian,Ming Shi,Fu-Sheng Wang,Lunzhi Dai,Min Wu,Gen Li,Guangyu Wang,Yong Peng,Zhiyong Qian,Canhua Huang,Johnson Yiu-Nam Lau,Zhenglin Yang,Yuquan Wei,Xiaobo Cen,Xiaozhong Peng,Chuan Qin,Kang Zhang,Guangwen Lu,Xiawei Wei

DOI: https://doi.org/10.1038/s41586-020-03108-4

IF: 64.8

2021-01-19

Nature

Abstract:A Correction to this paper has been published: https://doi.org/10.1007/s00125-020-03108-4.

multidisciplinary sciences
Corrigendum: A Comparison of COVID-19 Stigma and AIDS Stigma During the COVID-19 Pandemic: A Cross-Sectional Study in China

Manyun Li,Jiang Long,Xuyi Wang,Yanhui Liao,Yueheng Liu,Yuzhu Hao,Qiuxia Wu,Yanan Zhou,Yingying Wang,Yunfei Wang,Qianjin Wang,Yuejiao Ma,Shubao Chen,Tieqiao Liu

DOI: https://doi.org/10.3389/fpsyt.2022.856704

IF: 4.7

2022-01-01

Frontiers in Psychiatry

Abstract:[This corrects the article DOI: 10.3389/fpsyt.2021.782501.].
Author Correction: Tracking the evolution of anti-SARS-CoV-2 antibodies and long-term humoral immunity within 2 years after COVID-19 infection

Mariam Movsisyan,Nune Truzyan,Irina Kasparova,Armine Chopikyan,Ra'ed Sawaqed,Alexandra Bedross,Meline Sukiasyan,Karen Dilbaryan,Sanobar Shariff,Burhan Kantawala,Gohar Hakobjanyan,Gayane Petrosyan,Armine Hakobyan,Konstantin Yenkoyan

DOI: https://doi.org/10.1038/s41598-024-70482-8

IF: 4.6

2024-08-26

Scientific Reports

Abstract:Scientific Reports - Author Correction: Tracking the evolution of anti-SARS-CoV-2 antibodies and long-term humoral immunity within 2 years after COVID-19 infection

multidisciplinary sciences
Erratum: Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2023.1249100

IF: 7.3

2023-07-12

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.964525.].

immunology
Corrigendum: Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV

Shi Zou,Wei Guo,Songjie Wu,Fangzhao Ming,Yuting Tan,Mengmeng Wu,Weiming Tang,Ke Liang

DOI: https://doi.org/10.3389/fimmu.2024.1494940

2024-09-25

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.988304.].
Corrigendum: A matter of life or death: Productively infected and bystander CD4 T Cells in early HIV infection

Dechao Cao,Sushant Khanal,Ling Wang,Zhengke Li,Juan Zhao,Lam Nhat Nguyen,Lam Ngoc Thao Nguyen,Xindi Dang,Madison Schank,Bal Krishna Chand Thakuri,Jinyu Zhang,Zeyuan Lu,Xiao Y. Wu,Zheng D. Morrison,Mohamed El Gazzar,Shunbin Ning,Jonathan P. Moorman,Zhi Q. Yao

DOI: https://doi.org/10.3389/fimmu.2022.937057

IF: 7.3

2022-07-26

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2020.626431.].

immunology
Correction to: Low Prevalence of Nirmatrelvir-Ritonavir Resistance-Associated Mutations in SARS-CoV-2 Lineages From Botswana

DOI: https://doi.org/10.1093/ofid/ofae546

2024-09-30

Abstract:[This corrects the article DOI: 10.1093/ofid/ofae344.].
Corrigendum to Biologic Treatment of 4 HIV-Positive Patients: A Case Series and Literature Review

DOI: https://doi.org/10.1177/24755303231195885

Abstract:[This corrects the article DOI: 10.1177/2475530320954279.].
Author Correction: Host susceptibility and structural and immunological insight of S proteins of two SARS-CoV-2 closely related bat coronaviruses

Xiuyuan Ou,Ge Xu,Pei Li,Yan Liu,Fuwen Zan,Pan Liu,Jiaxin Hu,Xing Lu,Siwen Dong,Yao Zhou,Zhixia Mu,Zhiqiang Wu,Jianwei Wang,Qi Jin,Pinghuang Liu,Jian Lu,Xiangxi Wang,Zhaohui Qian

DOI: https://doi.org/10.1038/s41421-023-00597-1

IF: 38.079

2023-10-09

Cell Discovery

Abstract:Cell Discovery, Published online: 09 October 2023; doi:10.1038/s41421-023-00597-1 Author Correction: Host susceptibility and structural and immunological insight of S proteins of two SARS-CoV-2 closely related bat coronaviruses

cell biology
Corrigendum: COVIEdb: A Database for Potential Immune Epitopes of Coronaviruses.

Jingcheng Wu,Wenfan Chen,Jingjing Zhou,Wenyi Zhao,Yisheng Sun,Hanping Zhu,Pingping Yao,Shuqing Chen,Jianmin Jiang,Zhan Zhou

DOI: https://doi.org/10.3389/fphar.2020.646111

IF: 5.6

2021-01-01

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2020.572249.].
Correction: Silva Julian et al. Severe COVID-19 Outcomes in Five Latin American Countries in the Postvaccination Era. Viruses 2024, 16, 1025

Guilherme Silva Julian,Júlia Spinardi,Melissa Diaz-Puentes,Diana Buitrago,Ida Caterina García,Moe H. Kyaw

DOI: https://doi.org/10.3390/v16101590

2024-10-10

Viruses

Abstract:Viruses, Vol. 16, Pages 1590: Correction: Silva Julian et al. Severe COVID-19 Outcomes in Five Latin American Countries in the Postvaccination Era. Viruses 2024, 16, 1025 Viruses doi: 10.3390/v16101590 Authors: Guilherme Silva Julian Júlia Spinardi Melissa Diaz-Puentes Diana Buitrago Ida Caterina García Moe H. Kyaw In the original publication [...]

virology
Author Correction: Mucosal vaccine-induced cross-reactive CD8 + T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection

Baoling Ying,Tamarand L. Darling,Pritesh Desai,Chieh-Yu Liang,Igor P. Dmitriev,Nadia Soudani,Traci Bricker,Elena A. Kashentseva,Houda Harastani,Saravanan Raju,Meizi Liu,Aaron G. Schmidt,David T. Curiel,Adrianus C. M. Boon,Michael S. Diamond

DOI: https://doi.org/10.1038/s41590-024-01781-5

IF: 30.5

2024-02-16

Nature Immunology

Abstract:Nature Immunology - Author Correction: Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection

immunology
Author Correction: CCR5AS Lncrna Variation Differentially Regulates CCR5, Influencing HIV Disease Outcome

Smita Kulkarni,Alexandra Lied,Viraj Kulkarni,Marijana Ručević,Maureen P. Martin,Victoria E. Walker-Sperling,Stephen Anderson,Rodger Ewy,Sukhvinder Singh,Hoang Nguyen,Paul J. McLaren,Mathias Viard,Vivek Naranbhai,Chengcheng Zou,Zhaoyu Lin,Hiroyuki Gatanaga,Shinichi Oka,Masafumi Takiguchi,Chloe L. Thio,Joseph B. Margolick,Gregory D. Kirk,James J. Goedert,W. Keith Hoots,Steven G. Deeks,David W. Haas,Nelson Michael,Bruce D. Walker,Sylvie Le Gall,Fatema Z. Chowdhury,Xu G. Yu,Mary Carrington

DOI: https://doi.org/10.1038/s41590-019-0516-9

IF: 30.5

2019-01-01

Nature Immunology

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Leveraging South African HIV research to define SARS‐CoV‐2 immunity triggered by sequential variants of concern

Jinal N. Bhiman,Penny L. Moore

DOI: https://doi.org/10.1111/imr.13086

2022-05-24

Immunological Reviews

Abstract:Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus that causes coronavirus disease 2019 (COVID‐19), has shifted our paradigms about B cell immunity and the goals of vaccination for respiratory viruses. The development of population immunity, through responses directed to highly immunogenic regions of this virus, has been a strong driving force in the emergence of progressively mutated variants. This review highlights how the strength of the existing global virology and immunology networks built for HIV vaccine research enabled rapid adaptation of techniques, assays, and skill sets, to expeditiously respond to the SARS‐CoV‐2 pandemic. Allying real‐time genomic surveillance to immunological platforms enabled the characterization of immune responses elicited by infection with distinct variants, in sequential epidemic waves, as well as studies of vaccination and hybrid immunity (combination of infection‐ and vaccination‐induced immunity). These studies have shown that consecutive variants of concern have steadily diminished the ability of vaccines to prevent infection, but that increasing levels of hybrid immunity result in higher frequencies of cross‐reactive responses. Ultimately, this rapid pivot from HIV to SARS‐CoV‐2 enabled a depth of understanding of the SARS‐CoV‐2 antigenic vulnerabilities as population immunity expanded and diversified, providing key insights for future responses to the SARS‐CoV‐2 pandemic.

immunology
Correction: Lacy et al. Human Rabies Treatment—From Palliation to Promise. Viruses 2024, 16, 160

Marian Lacy,Nonthapan Phasuk,Stephen J. Scholand

DOI: https://doi.org/10.3390/v16020264

2024-02-07

Viruses

Abstract:Viruses, Vol. 16, Pages 264: Correction: Lacy et al. Human Rabies Treatment—From Palliation to Promise. Viruses 2024, 16, 160 Viruses doi: 10.3390/v16020264 Authors: Marian Lacy Nonthapan Phasuk Stephen J. Scholand In the original publication [...]

virology
Corrigendum: SARS-CoV-2 evolution among patients with immunosuppression in a nosocomial cluster of a Japanese medical center during the Delta (AY.29 sublineage) surge

Yoshie Hosaka,Yan Yan,Toshio Naito,Rieko Oyama,Koji Tsuchiya,Norio Yamamoto,Shuko Nojiri,Satoshi Hori,Kazuhisa Takahashi,Yoko Tabe

DOI: https://doi.org/10.3389/fmicb.2024.1478638

2024-08-23

Abstract:[This corrects the article DOI: 10.3389/fmicb.2023.944369.].
Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Ugur Sahin,Alexander Muik,Evelyna Derhovanessian,Isabel Vogler,Lena M. Kranz,Mathias Vormehr,Alina Baum,Kristen Pascal,Jasmin Quandt,Daniel Maurus,Sebastian Brachtendorf,Verena Lörks,Julian Sikorski,Rolf Hilker,Dirk Becker,Ann-Kathrin Eller,Jan Grützner,Carsten Boesler,Corinna Rosenbaum,Marie-Cristine Kühnle,Ulrich Luxemburger,Alexandra Kemmer-Brück,David Langer,Martin Bexon,Stefanie Bolte,Katalin Karikó,Tania Palanche,Boris Fischer,Armin Schultz,Pei-Yong Shi,Camila Fontes-Garfias,John L. Perez,Kena A. Swanson,Jakob Loschko,Ingrid L. Scully,Mark Cutler,Warren Kalina,Christos A. Kyratsous,David Cooper,Philip R. Dormitzer,Kathrin U. Jansen,Özlem Türeci

DOI: https://doi.org/10.1038/s41586-020-03102-w

IF: 64.8

2021-01-19

Nature

Abstract:A Correction to this paper has been published: https://doi.org/10.1038/s41586-020-03102-w

multidisciplinary sciences
Corrigendum to Prevalence of syphilis among people living with HIV who attend a large urban antiretroviral therapy clinic in Panama: a cross-sectional epidemiological study

DOI: https://doi.org/10.1177/20499361241263641

2024-06-20

Abstract:[This corrects the article DOI: 10.1177/20499361241256290.].
A Study of Two Cases Co-Infected with SARS-CoV-2 and Human Immunodeficiency Virus

Rong Zhang,Xiaohua Chen,Yuqing Huang,Qi Zhang,Yan Cheng,Nan Zhang,Haibo Zhang,Bo Yang,Fang Liu,Yingle Liu,Ke Lan

DOI: https://doi.org/10.1007/s12250-020-00280-9

IF: 6.947

2020-01-01

Virologica Sinica

Abstract:Dear Editor,Since December 2019, A new type of coronavirus pneumonia （coronavirus disease 2019, COVID-19） has become endemic in Wuhan, China. So far, COVID-19 has developed into a global epidemic. The body’s immune system plays an important role in the fight against COVID-19. Here,

Publisher Correction: SARS-CoV-2 and HIV-1 — a tale of two vaccines

Corrigendum To: Genomic Diversity of Severe Acute Respiratory Syndrome–Coronavirus 2 in Patients with Coronavirus Disease 2019

Publisher Correction: A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity

Corrigendum: A Comparison of COVID-19 Stigma and AIDS Stigma During the COVID-19 Pandemic: A Cross-Sectional Study in China

Author Correction: Tracking the evolution of anti-SARS-CoV-2 antibodies and long-term humoral immunity within 2 years after COVID-19 infection

Erratum: Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity

Corrigendum: Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV

Corrigendum: A matter of life or death: Productively infected and bystander CD4 T Cells in early HIV infection

Correction to: Low Prevalence of Nirmatrelvir-Ritonavir Resistance-Associated Mutations in SARS-CoV-2 Lineages From Botswana

Corrigendum to Biologic Treatment of 4 HIV-Positive Patients: A Case Series and Literature Review

Author Correction: Host susceptibility and structural and immunological insight of S proteins of two SARS-CoV-2 closely related bat coronaviruses

Corrigendum: COVIEdb: A Database for Potential Immune Epitopes of Coronaviruses.

Correction: Silva Julian et al. Severe COVID-19 Outcomes in Five Latin American Countries in the Postvaccination Era. Viruses 2024, 16, 1025

Author Correction: Mucosal vaccine-induced cross-reactive CD8 + T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection

Author Correction: CCR5AS Lncrna Variation Differentially Regulates CCR5, Influencing HIV Disease Outcome

Leveraging South African HIV research to define SARS‐CoV‐2 immunity triggered by sequential variants of concern

Correction: Lacy et al. Human Rabies Treatment—From Palliation to Promise. Viruses 2024, 16, 160

Corrigendum: SARS-CoV-2 evolution among patients with immunosuppression in a nosocomial cluster of a Japanese medical center during the Delta (AY.29 sublineage) surge

Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Corrigendum to Prevalence of syphilis among people living with HIV who attend a large urban antiretroviral therapy clinic in Panama: a cross-sectional epidemiological study

A Study of Two Cases Co-Infected with SARS-CoV-2 and Human Immunodeficiency Virus